Karyopharm Therapeutics Inc. (KPTI) is a publicly traded Healthcare sector company. As of July 27, 2026, KPTI trades at $7.41 with a market cap of $167.93M and a P/E ratio of -0.46. KPTI moved +4.37% today. Year to date, KPTI is +1.37%; over the trailing twelve months it is +67.27%. Its 52-week range spans $3.51 to $12.90. Analyst consensus is strong buy with an average price target of $12.00. Rallies surfaces KPTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
KPTI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KPTI recently traded at $7.41. Market cap is $167.93M. P/E ratio is -0.46. Revenue is $151.12M.
| Metric | Value |
|---|---|
| Price | $7.41 |
| Market Cap | $167.93M |
| P/E Ratio | -0.46 |
| EPS | $-16.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.90 |
| 52-Week Low | $3.51 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $151.12M |
| Net Income | $-194.97M |
| Gross Margin | 0.00% |
4 analysts cover KPTI: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.00.